These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9210502)

  • 1. Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts.
    Laine J; Hoppu K; Jalanko H; Rönnholm K; Holmberg C
    Transplantation; 1997 Jun; 63(12):1768-72. PubMed ID: 9210502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of conventional oral cyclosporine and cyclosporine microemulsion formulations in children with a liver transplant.
    Hoppu K; Jalanko H; Laine J; Holmberg C
    Transplantation; 1996 Jul; 62(1):66-71. PubMed ID: 8693548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
    D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
    Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of (1:1) cyclosporine A conversion to its microemulsion formulation on the kidney function of patients with cardiac allografts.
    Khajehdehi P; Yip D; Bastani B
    Clin Transplant; 1999 Apr; 13(2):176-80. PubMed ID: 10202614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
    Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis.
    van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF
    Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation.
    Cooney GF; Dunn SP; Sommerauer J; Lindsay C; McDiarmid S; Choc MG; Smith HT; Chang CT; Wong RL
    Liver Transpl Surg; 1999 Mar; 5(2):112-8. PubMed ID: 10071350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
    Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
    PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving A quadruple immunosuppressive regimen: the value of C2 blood levels.
    Ferraresso M; Ghio L; Zacchello G; Murer L; Ginevri F; Perfumo F; Zanon GF; Fontana I; Amore A; Edefonti A; Vigano S; Cardillo M; Scalamogna M
    Transplantation; 2005 May; 79(9):1164-8. PubMed ID: 15880063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patients.
    Kovarik JM; Kallay Z; Mueller EA; van Bree JB; Arns W; Renner E
    Transpl Int; 1995; 8(5):335-9. PubMed ID: 7576013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
    Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
    Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.
    Benz K; Plank C; Griebel M; Montoya C; Dötsch J; Klare B
    Pediatr Transplant; 2006 May; 10(3):331-6. PubMed ID: 16677357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
    Pape L; Ehrich JH; Offner G
    Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.